Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Douglas Gilchrist-Scott"'
Autor:
Douglas Gilchrist-Scott, Wilberto Nieves-Neira, Shohreh Shahabi, Brandon-Luke L. Seagle, Stephen Graves, Anna E. Strohl
Publikováno v:
JCO Clinical Cancer Informatics. :1-15
Purpose To estimate whether the number of lymph nodes removed during surgery is associated with overall survival among women with endometrial cancer. Methods We performed a retrospective cohort study of women with node-negative, stage I to IIIB endom
Publikováno v:
American Journal of Obstetrics and Gynecology. 222:S790-S791
Publikováno v:
American journal of obstetrics and gynecology. 221(3)
Publikováno v:
Obstetrics & Gynecology. 128:429-435
OBJECTIVE:To evaluate the association of a forceps simulation training curriculum for obstetrics residents on rates of severe perineal lacerations after forceps deliveries.METHODS:This was a retrospective cohort study. We created a novel simulation c
Autor:
Margaret G. Mueller, Douglas Gilchrist-Scott, Emily S. Miller, Oluwateniola Brown, Kimberly Kenton, Christina Lewicky-Gaupp
Publikováno v:
Obstetrics & Gynecology. 135:130S
Publikováno v:
Pediatrics. 140
BACKGROUND: Child enrollment in Medicaid managed care (MMC) has expanded dramatically, primarily through state mandates. Care coordination is a key metric in MMC evaluation because it drives much of the proposed cost savings and may be associated wit
Publikováno v:
Obstetrics & Gynecology. 129:205-206
Publikováno v:
Obstetrics & Gynecology. 128:1449-1449
Autor:
Timothy M. Kuzel, Martin S. Tallman, Al B. Benson, Elizabeth A. Richey, Steven Trifilio, Dennis W. Raisch, Narissa J. Nonzee, Steven Hirschfeld, Veena Shankaran, June M. McKoy, Dennis P. West, E. Alison Lyons, Oliver Sartor, Douglas Gilchrist-Scott, Charles L. Bennett, Jonathan R. Nebeker, Beatrice J. Edwards, Kenneth R. Carson, Antonio J. Grillo-Lopez, Thanh Ha Luu
Purpose Accelerated approval (AA) was initiated by the US Food and Drug Administration (FDA) to shorten development times of drugs for serious medical illnesses. Sponsors must confirm efficacy in postapproval trials. Confronted with several drugs tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25e097c0099b8543061718402531428
https://europepmc.org/articles/PMC2744277/
https://europepmc.org/articles/PMC2744277/